AGTR1 and type 2 diabetes mellitus: Inhibition of the renin-angiotensin system (RAS), especially through the use of angiotensin II type 1 receptor blockers (ARB) such as valsartan, was reported to have a preventive effect on type 2 diabetes [15,16].